Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells
Authors:
- Maxim V. ChevliakovMCMaxim V. Chevliakov
- Gopinath TiruchinapallyGTGopinath Tiruchinapally
- Yasemin Yuksel DurmazYDYasemin Yuksel Durmaz
- Sibu P. KuruvillaSKSibu P. Kuruvilla
- Mohamed E.H. ElSayedMEMohamed E.H. ElSayed
- 1 June 2013
- journal article
- Published by Elsevier in Biomaterials
- Vol. 34 (19) , 4655-4666
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytesJournal of Molecular and Cellular Cardiology, 2012
- Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug deliveryAdvanced Drug Delivery Reviews, 2012
- Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticlesNanotoxicology, 2011
- Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human HepatocytesDrug Metabolism and Disposition, 2011
- Comparative Biodistribution of PAMAM Dendrimers and HPMA Copolymers in Ovarian-Tumor-Bearing MiceBiomacromolecules, 2010
- Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancerBiomaterials, 2010
- Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymersJournal of Controlled Release, 2005
- Macromolecular TherapeuticsClinical Pharmacokinetics, 2003
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- The Effect of Structure upon the Reactions of Organic Compounds. Benzene DerivativesJournal of the American Chemical Society, 1937